Jesudason, David

Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial

Wittert, G., Bracken, K., Robledo, K. P., Grossmann, M., Yeap, B. B., Handelsman, D. J., Stuckey, B., Conway, A., Inder, W., McLachlan, R., et al. (2021) · The Lancet Diabetes & Endocrinology

Hormonal and reproductive studiesDiabetes Treatment and Management

Cited by 362

Macrovascular Risk and Diagnostic Criteria for Type 2 Diabetes

Jesudason, D. R., Dunstan, K., Leong, D., & Wittert, G. A. (2003) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 77

Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium–Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction

Umapathysivam, M. M., Gunton, J., Stranks, S. N., & Jesudason, D. (2024) · Diabetes Care

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 57